Geode Capital Management, LLC 4 D Molecular Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,036,545 shares of FDMT stock, worth $8.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,036,545

Previous 1,060,891 2.29%

Holding current value

$8.72 Million

Previous $22.3 Million 49.68%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.81 - $27.22 $263,180 - $662,698	-24,346 Reduced 2.29%	1,036,545 $11.2 Million
Q2 2024 Aug 09, 2024	BUY	$20.93 - $30.01 $3.94 Million - $5.65 Million	188,228 Added 21.57%	1,060,891 $22.3 Million
Q1 2024 May 13, 2024	BUY	$17.03 - $35.87 $1.61 Million - $3.39 Million	94,501 Added 12.14%	872,663 $27.8 Million
Q4 2023 Feb 13, 2024	BUY	$9.76 - $21.25 $356,210 - $775,561	36,497 Added 4.92%	778,162 $15.8 Million
Q3 2023 Nov 13, 2023	BUY	$12.64 - $19.76 $655,864 - $1.03 Million	51,888 Added 7.52%	741,665 $9.44 Million
Q2 2023 Aug 11, 2023	BUY	$15.16 - $23.26 $1.7 Million - $2.6 Million	111,855 Added 19.35%	689,777 $12.5 Million
Q1 2023 May 15, 2023	BUY	$15.45 - $23.19 $250,058 - $375,330	16,185 Added 2.88%	577,922 $9.93 Million
Q4 2022 Feb 13, 2023	BUY	$6.85 - $25.46 $224,686 - $835,113	32,801 Added 6.2%	561,737 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.48 $251,332 - $414,554	36,111 Added 7.33%	528,936 $4.25 Million
Q2 2022 Aug 12, 2022	BUY	$5.68 - $15.99 $80,667 - $227,089	14,202 Added 2.97%	492,825 $3.44 Million
Q1 2022 May 13, 2022	SELL	$13.16 - $22.64 $50,192 - $86,348	-3,814 Reduced 0.79%	478,623 $7.24 Million
Q4 2021 Feb 11, 2022	BUY	$19.56 - $32.94 $2.74 Million - $4.62 Million	140,219 Added 40.97%	482,437 $10.6 Million
Q3 2021 Nov 12, 2021	BUY	$22.73 - $36.04 $3.97 Million - $6.3 Million	174,784 Added 104.39%	342,218 $9.23 Million
Q2 2021 Aug 13, 2021	BUY	$22.2 - $42.29 $469,219 - $893,841	21,136 Added 14.45%	167,434 $4.03 Million
Q1 2021 May 12, 2021	BUY	$35.94 - $52.67 $4.8 Million - $7.03 Million	133,518 Added 1044.74%	146,298 $6.35 Million
Q4 2020 Feb 12, 2021	BUY	$38.43 - $47.36 $491,135 - $605,260	12,780 New	12,780 $529,000

Others Institutions Holding FDMT

# of Institutions

144

Shares Held

57.7M

Call Options Held

137K

Put Options Held

111K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $272M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC 4 D Molecular Therapeutics, Inc. Transaction History